These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7591467)

  • 1. Palmoplantar keratoderma associated with dermatopathia pigmentosa reticularis: successful treatment with etretinate.
    Arthur EA; Brod BA; Kantor GR
    Int J Dermatol; 1995 Sep; 34(9):645-6. PubMed ID: 7591467
    [No Abstract]   [Full Text] [Related]  

  • 2. [Voerner-type palmoplantar keratoderma. Treatment with etretinate].
    Ortega Resinas M; Quintana del Olmo J; Yebra Sotillo I; Camacho Martinez F
    Med Cutan Ibero Lat Am; 1986; 14(3):193-7. PubMed ID: 2942739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmoplantar keratoderma with amyotrophy.
    Jacyk WK; Bill PL
    Dermatologica; 1988; 176(5):251-6. PubMed ID: 2968285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutilating keratoderma of Vohwinkel: successful treatment with etretinate.
    Sivayathorn A; Tongnak S
    J Med Assoc Thai; 1985 Oct; 68(10):546-51. PubMed ID: 2934494
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose etretinate shows promise in management of punctate palmoplantar keratoderma type 1: Case report and review of the published work.
    Nomura T; Moriuchi R; Takeda M; Suzuki S; Kikuchi K; Ito T; Shimizu H; Shimizu S
    J Dermatol; 2015 Sep; 42(9):889-92. PubMed ID: 25919143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutilating palmoplantar keratoderma successfully treated with etretinate.
    Wereide K
    Acta Derm Venereol; 1984; 64(6):566-9. PubMed ID: 6084939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Punctate palmoplantar keratoderma with pigmentary lesions on the dorsa of feet and ankles: successful treatment with a combination of low-dose oral etretinate and topical calcipotriol.
    Horikoshi M; Kuroda K; Tajima S
    J Dermatol; 2004 Jun; 31(6):469-72. PubMed ID: 15235186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dermatoses difficult to treat. Their treatment with an aromatic retinoid (etretinate)].
    Solano E; Hidalgo H
    Med Cutan Ibero Lat Am; 1983; 11(5):369-71. PubMed ID: 6230492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of etretinate treatment in paraneoplastic plamoplantar hyperkeratosis.
    Berardesca E; Del Forno C; Vignini M
    Br J Dermatol; 1987 Jul; 117(1):132. PubMed ID: 2958074
    [No Abstract]   [Full Text] [Related]  

  • 10. Unusual cases of Meleda keratoderma treated with aromatic retinoid etretinate.
    Brambilla L; Pigatto PD; Boneschi V; Altomare GF; Finzi AF
    Dermatologica; 1984; 168(6):283-6. PubMed ID: 6235136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Punctate palmoplantar keratoderma type 1: a novel AAGAB mutation and efficacy of etretinate.
    Nomura T; Yoneta A; Pohler E; Suzuki S; Osawa R; Mizuno O; Ohguchi Y; Nomura Y; Yamashita T; McLean WH; Shimizu H
    Acta Derm Venereol; 2015 Jan; 95(1):110-1. PubMed ID: 24573067
    [No Abstract]   [Full Text] [Related]  

  • 12. Keratodermia palmoplantare papuloverrucoides progressiva: successful treatment with etretinate.
    Baran R; Juhlin L
    J Am Acad Dermatol; 1983 May; 8(5):700-2. PubMed ID: 6223052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Papillon-Lefèvre syndrome with etretinate.
    Driban NE; Jung JR
    J Am Acad Dermatol; 1988 Mar; 18(3):583-4. PubMed ID: 2965168
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of keratoderma hereditaria mutilans with an aromatic retinoid.
    Chang Sing Pang AF; Oranje AP; Vuzevki VD; Stolz E
    Arch Dermatol; 1981 Apr; 117(4):225-8. PubMed ID: 6452098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etretinate: management of keratoma hereditaria mutilans in four family members.
    Rivers JK; Duke EE; Justus DW
    J Am Acad Dermatol; 1985 Jul; 13(1):43-9. PubMed ID: 3161912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosinemia type II with incomplete Richner-Hanhart's syndrome.
    Lestringant GG
    Int J Dermatol; 1988; 27(1):43-4. PubMed ID: 2964425
    [No Abstract]   [Full Text] [Related]  

  • 17. Etretinate as an effective adjunctive therapy for recalcitrant palmar/plantar hyperkeratosis in patients with erythrodermic cutaneous T cell lymphoma undergoing photopheresis.
    Lim HW; Harris HR
    Dermatol Surg; 1995 Jul; 21(7):597-9. PubMed ID: 7606369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circumscribed palmo-plantar keratosis associated with corneal dystrophy and biochemical analysis of the involved stratum corneum--including the effect of retinoid].
    Yoshiike T; Takamori K; Ogawa H
    Nihon Hifuka Gakkai Zasshi; 1982 Jun; 92(7):743-9. PubMed ID: 6184504
    [No Abstract]   [Full Text] [Related]  

  • 19. Tyrosinaemia type II (Richner-Hanhart syndrome)--report of two cases treated with etretinate.
    Fraser NG; MacDonald J; Griffiths WA; McPhie JL
    Clin Exp Dermatol; 1987 Nov; 12(6):440-3. PubMed ID: 2974325
    [No Abstract]   [Full Text] [Related]  

  • 20. [Systemic retinoid therapy with etretinate in pachyonychia congenita].
    Hoting E; Wassilew SW
    Hautarzt; 1985 Sep; 36(9):526-8. PubMed ID: 2933371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.